Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Isoquinoline compounds >  7-Bromoisoquinoline

7-Bromoisoquinoline

Basic information Safety Supplier Related

7-Bromoisoquinoline Basic information

Product Name:
7-Bromoisoquinoline
Synonyms:
  • 7-BROMOISOQUINOLINE
  • 7-isoquinoline
  • isoquinolin-7-amine
  • 7-Bromo-2-azanaphthalene
  • Isoquinoline, 7-bromo-
  • 7-Bromoisoquinoline ISO 9001:2015 REACH
CAS:
58794-09-5
MF:
C9H6BrN
MW:
208.05
EINECS:
676-321-0
Product Categories:
  • Aromatics
  • Building Blocks
  • Isoquinoline
  • Isoquinoline Derivertives
  • Heterocycles
Mol File:
58794-09-5.mol
More
Less

7-Bromoisoquinoline Chemical Properties

Melting point:
69.0 to 73.0 °C
Boiling point:
312.3±15.0 °C(Predicted)
Density 
1.564±0.06 g/cm3(Predicted)
Flash point:
113℃
storage temp. 
Sealed in dry,Room Temperature
solubility 
Acetonitrile (Slightly), Chloroform (Slightly), Methanol (Slightly)
form 
Solid
pka
4.62±0.10(Predicted)
color 
White to Pale Beige
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26
WGK Germany 
3
HazardClass 
IRRITANT
HS Code 
2933499090
More
Less

7-Bromoisoquinoline Usage And Synthesis

Description

7-Bromoisoquinoline is a synthetic intermediate useful for pharmaceutical synthesis.

Chemical Properties

Off-White Solid

Uses

7-Bromoisoquinoline (cas# 58794-09-5) is a compound useful in organic synthesis. It can be used for the preparation of estrone cortistatin analogs via Suzuki-Miyaura coupling. It could also be used for the preparation of pyrazolopyrimidinamine derivatives.

Synthesis

3132-99-8

22483-09-6

58794-09-5

General method: Aminoacetaldehyde dimethyl acetal (3.0 eq.) was added to a solution of m-bromobenzaldehyde (1.0 eq.) in toluene (30 mL). The reaction mixture was refluxed at 120°C (using a Dean-Stark device to remove water). After the feedstock was completely consumed, the reaction mixture was concentrated and the concentrate was redissolved. Concentrated H2SO4 (2 mL) and P2O5 (0.5 mL) were slowly added to the cooled concentrate. Subsequently, the reaction mixture was heated at 160 °C for 30 min, cooled to room temperature, neutralized with 10 M NaOH, extracted with EtOAc, and concentrated to dryness. The residue was purified by fast column chromatography (FCC) to afford 6-bromoisoquinoline (14b, 30 mg, 0.14 mmol, 14% yield) and 7-bromoisoquinoline (14c, 99 mg, 0.47 mmol, 22% yield) [20,21]. Ethyl chloroformate (1.0 eq.) was added dropwise to a DCM solution of isoquinoline 14b or 14c (1.0 eq.) at 0 °C, maintained at temperature and stirred for 30 min, followed by the addition of 2-trimethylsilylthiazole (1.0 eq.). The reaction mixture was stirred at room temperature for 3 hours, concentrated to dryness and the residue was purified by FCC. The purified product was dissolved in benzene (5 mL), o-chloroquinone (1.0 eq.) was added and the reaction mixture was refluxed for 5 hours. Upon completion of the reaction, it was diluted with 5% NaOH (10 mL), extracted by DCM and concentrated to dryness. The final product was purified by FCC to give the target compounds 9b and 9c.

References

[1] Molecules, 2017, vol. 22, # 8,

7-Bromoisoquinoline Preparation Products And Raw materials

Raw materials

7-BromoisoquinolineSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Bridge Organics
Tel
+1269-649-4200
Email
ab@bridgeorganics.com
ChemFuture PharmaTech (Jiangsu) Ltd
Tel
5108538618
Email
suger.wang@chemfuture.com